TKNO Alpha Teknova, Inc.
USHealthcareAs of 2026-07-10 12:40
Why TKNO matters now
Alpha Teknova, Inc. (TKNO) is a US stock in Healthcare. The latest InvestLog snapshot shows $5.25 with -3.14% on the session and $281.5M in market capitalization; recent performance reads 1-month +40.86% and YTD +37.89%.
The latest financial table shown here is Q1 2026, with revenue of $11.1M, net income of $-4.6M, and EPS of $-0.09. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield -3.2%.
The latest indexable market news headline is "Alpha Teknova, Inc. (TKNO) Q1 2026 Earnings Call Transcript" from Seeking Alpha.
Additional event context on this page matters because analyst consensus is Buy with a median target of $—; recent insider activity includes DEMSKI MARTHA J filing A-Award. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
—
PEG
—
P/B
4.33
P/S
6.72
EV/EBITDA
-29.24
DCF Value
$-10.03
FCF Yield
-3.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
33.3%
Operating Margin
-39.0%
Net Margin
-41.1%
ROE
-24.3%
ROA
-17.4%
ROIC
-17.4%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $11.1M | $-4.6M | $-0.09 |
| Q4 2025 | $10.0M | $-4.8M | $-0.09 |
| FY 2025 | $40.5M | $-17.3M | $-0.32 |
| Q3 2025 | $10.5M | $-4.3M | $-0.08 |
Analyst Ratings
Consensus
Buy
Target (Consensus)
$—
Target (Median)
$—
Target Range
$— - $—
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
US
Exchange
—
Beta
0.63
Alpha Teknova, Inc. supplies vital scientific reagents to the life sciences sector across both the United States and international markets. These crucial materials play a key role in facilitating the exploration, evolution, and ultimate production of biopharmaceutical goods, such as advanced drug treatments, new vaccines, and molecular diagnostic solutions. The company's product offerings encompass pre-filled media plates designed for cell growth and replication; liquid cell culture media and complementary supplements that promote cellular proliferation; and various molecular biology reagents used for the handling, rehydration, and purification of samples. Teknova caters to a diverse clientele within the life sciences arena, including pharmaceutical companies, biotechnology firms, contract development and manufacturing organizations (CDMOs), in vitro diagnostic businesses, and academic and governmental research facilities. Founded in 1996, Alpha Teknova's main office is situated in Hollister, California.